Before the pandemic, medical professionals and public health officials were reluctant to embrace at-home testing due to concerns that users’ would have trouble performing a test or that individuals would overreact to test results. But, the at-home COVID-19 tests have accelerated interests in developing more at-home testing for other diseases, according the Journal report.
Cue Health, a San Diego-based healthcare technology company, is in active clinical trials for its at-home flu test and is developing others, including an at-home chlamydia test.
Detect Inc., which developed an at-home COVID-19 test, is creating an at-home strep-throat test and a combined COVID-19 and flu test.
“One of the most important, enduring changes in the pandemic will be a shift in how people view diagnostics at home,” Ayub Khattak, chief executive of Cue Health, told the Journal. “It is better for people to have access to information more quickly.”
